APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 130 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,750,000 | -35.1% | 113,472 | -68.7% | 0.03% | -3.7% |
| Q3 2021 | $11,938,000 | -60.2% | 362,204 | -23.8% | 0.03% | -60.3% |
| Q2 2021 | $30,022,000 | +81.9% | 475,038 | +23.5% | 0.07% | +58.1% |
| Q1 2021 | $16,509,000 | +41.0% | 384,731 | +87.9% | 0.04% | +26.5% |
| Q4 2020 | $11,711,000 | +24.8% | 204,740 | -34.2% | 0.03% | +3.0% |
| Q3 2020 | $9,382,000 | -47.7% | 310,980 | -43.4% | 0.03% | -62.9% |
| Q2 2020 | $17,948,000 | +55.3% | 549,538 | +27.4% | 0.09% | -5.3% |
| Q1 2020 | $11,556,000 | +74.1% | 431,339 | +99.0% | 0.09% | +370.0% |
| Q4 2019 | $6,638,000 | +89.6% | 216,777 | +49.2% | 0.02% | +66.7% |
| Q3 2019 | $3,501,000 | – | 145,313 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |